Betting Against Beta (for Retail)
Lever up low-beta assets and short high-beta ones to harvest the beta anomaly.
A real academic factor, but the retail version is eaten alive by leverage, shorting and transaction costs.
- Why it fails
- The published BAB factor depends on leverage, short positions and tight execution; net of realistic retail transaction costs the documented edge is largely eroded.
- When / how it stopped
- The anomaly remains in the academic literature, but later trading-cost studies showed that low-Sharpe, high-turnover factors like BAB lose much of their paper return once realistic frictions are applied to the implementable version.
Betting against beta (BAB) is one of the better-supported anomalies in the academic literature. The intuition is clean: leverage-constrained investors bid up high-beta assets, leaving them overpriced and low-beta assets underpriced. Frazzini and Pedersen (2014) formalized this and showed a long-leverage-low-beta, short-high-beta portfolio earned a significant premium across many markets and asset classes.
That is the paper version. The retail version is a different animal.
The published factor leans on three things a small account does badly:
- Leverage on the low-beta long leg — retail financing is far more expensive than the institutional rate the academic portfolio assumes.
- Shorting the high-beta leg — often limited, hard to borrow, or simply costly for retail brokers.
- Frequent rebalancing to keep the portfolio beta-neutral — which means high turnover, and turnover is where costs compound.
Novy-Marx and Velikov (2016) is the relevant honesty check here: they cataloged anomalies alongside their trading costs and found that modest-Sharpe, high-turnover strategies surrender much of their headline return once realistic frictions are applied. BAB sits squarely in that bucket.
So this is not a “the anomaly is fake” entry. The premium is documented and may persist for low-cost institutional desks. But the implementable retail version — net of leverage, borrow and spread — has largely eroded the edge. For a small account, the gap between the paper factor and the tradable factor is the whole story.
Sources
- Frazzini & Pedersen (2014), "Betting Against Beta", Journal of Financial Economics
- Novy-Marx & Velikov (2016), "A Taxonomy of Anomalies and Their Trading Costs", Review of Financial Studies
Frequently asked
Does betting against beta work for retail traders in 2026?
The factor is well documented academically (Frazzini & Pedersen, 2014), but the retail implementation is the problem. The strategy requires leveraging low-beta assets, shorting high-beta ones, and rebalancing frequently. Later work on trading costs (Novy-Marx & Velikov, 2016) showed that high-turnover, modest-Sharpe factors lose much of their headline return once realistic frictions are applied. For a small retail account paying retail borrow, financing and spread costs, the net edge is largely eroded.
Why is betting against beta hard to profit from in practice?
The paper return assumes you can lever the long leg cheaply and short the high-beta leg cleanly, then rebalance often without slippage. Retail traders face higher financing rates, limited or expensive shorting, wider spreads and more turnover drag than the idealized academic portfolio. Those frictions fall hardest on exactly the kind of low-Sharpe, high-turnover factor BAB is, which is why the documented decay shows up most in the implementable version.
Not investment advice — your mileage may vary, but the burden of proof is on the person claiming an edge. This entry describes general research and published evidence (or its absence), not a recommendation. See the full disclaimer.